With our broad portfolio of mechanistic cellular assays, we deepen the understanding of your drug discovery program. We help you to select the best drug candidates, elucidate the molecular drivers of efficacy, and identify biomarker candidates. NUVISAN’s scientists develop robust and relevant scalable cell-based assay solutions so that your drug discovery quest has the best chance of success. Based on many years of experience with various successful pharmaceutical projects for our clients, we offer a wide range of mechanistic cellular assays that meet industry quality standards.
We offer:
- state-of-the-art in vitro safety level S1 and S2 facilities fully equipped to support all aspects of drug discovery and development
- expansive knowledge in a wide range of disease areas and modalities
- proven track record of successfully translating drug discovery programs into the clinic
- a broad repertoire, from single-parameter assays (e.g., ATP production) to complex readouts (e.g., high-content imaging, flow cytometry, and next-generation sequencing)
- an increasing repertoire of ready-to-use solutions
- development of robust, scalable customized assays for different biology questions, therapeutic targets, and modalities
